Search - tctmd.com

Displaying 501 - 520 of 521

Sort: Relevancy | Date

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

Leah Lawrence

January 10, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

News Daily News

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Kim Dalton

January 14, 2009

CME

Optimizing the Duration of DAPT following PCI

CME

Advertisement

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

New-Generation DES Reduce Restenosis, Stent Thrombosis

Paclitaxel Balloon Maintains Advantage at 5 Years

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Higher Long-term Mortality for Women Undergoing Primary PCI

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

TCTMD’s Top 10 Most Popular News Stories for 2010

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Optimizing the Duration of DAPT following PCI

Updates on Onyx ONE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content